Pharmaceutical composition for treating hyperuricemia and preparation method thereof

Abstract

The invention discloses a pharmaceutical composition for treating hyperuricemia and a preparation method thereof. The pharmaceutical composition is prepared from the following raw material medicines in parts by weight: 2-8 parts of semen coicis, 2-8 parts of Chinese wolfberries, 0.5-3 parts of ampelopsis grossedentata and 0.5-3 parts of licorice roots. The preparation method comprises the following steps: respectively weighing the above desired parts by weight of the semen coicis, the Chinese wolfberries, the ampelopsis grossedentata and the licorice roots for later use; soaking the semen coicis, the Chinese wolfberries and the licorice roots in water, and then successively conducting heating reflux extraction and concentrating to form an extract powder; soaking the ampelopsis grossedentata in water, carrying out heating reflux extraction, and performing concentrating to form another extract powder; and uniformly mixing the obtained extract powders, and adding auxiliary materials to prepare a preparation. Pharmacodynamic tests show that the both medicinal and edible pharmaceutical composition provided by the invention has the effects of invigorating the spleen, tonifying the kidneyand tonifying the liver so as to address root causes and also has the effects of clearing away heat and toxic materials and resolving dampness so as to alleviate symptoms, can remarkably reduce uricacid, and has a relatively good protection effect on function injuries of the liver and the kidney and on pathological changes of the kidney.

Description

technical field [0001] The invention belongs to the technical field of Chinese herbal medicines, and in particular relates to a pharmaceutical composition for treating hyperuricemia and a preparation method thereof. Background technique [0002] Hyperuricemia (HUA) is a metabolic disease caused by purine metabolism disorder. Various reasons lead to excessive production of uric acid in the body or decreased excretion by the kidneys, resulting in excessive urate content in the extracellular fluid. A clinically multiple disease in a saturated state. The international diagnostic criteria for hyperuricemia is defined as a normal purine diet, 2 fasting blood uric acid levels on different days > 420 μmoL / L (7 mg / dL) for men and > 357 μmoL / L (6 mg / dL) for women. Asymptomatic hyperuricemia is hyperuricemia without gout. Its incidence is related to many factors, such as dietary factors, age, gender, genetics, region, etc.; with the improvement of economic level and the change ...

AI Technical Summary

Problems solved by technology

[0004] As mentioned above, western medicine has different degrees of side effects and risks such as skin damage, cardiovascular events, and liver damage in the treatment of hyperuricemia, and its clinical application is subject to certain restrictions

Images